ArticlePDF Available

Cronkhite-Canada syndrome associated with rib fractures: A case report

Authors:

Abstract and Figures

Cronkhite-Canada syndrome (CCS) is a rare multiple gastrointestinal polyposis. Up till now, many complications of CCS have been reported in the literature, but rib fracture is not included. We report a case of a 58-year-old man who was admitted to our hospital with a 6-month history of frequent diarrhea, intermittent hematochezia and a weight loss of 13 kg. On admission, physical examination revealed alopecia of the scalp, hyperpigmentation of the hands and soles, and dystrophy of the fingernails. Laboratory data revealed hypocalcaemia and hypoproteinemia. Esophagogastroduodenoscopy, video capsule endoscopy and colonoscopy revealed various sizes of generalized gastrointestinal polyps. Histological examination of the biopsy specimens obtained from the stomach and the colon showed adenomatous polyp and inflammatory polyp respectively. Thus, a diagnosis of CCS was made. After treatment with corticosteroids for 24 days and nutritional support for two months, his clinical condition improved. Two months later, he was admitted to our hospital for the second time with frequent diarrhea and weight loss. The chest radiography revealed fractures of the left sixth and seventh ribs. Examinations, including emission computed tomography, bone densitometry test, and other serum parameters, were performed, but could not identify the definite etiology of the rib fractures. One month later, the patient suffered from aggravating multiple rib fractures due to the ineffective treatment, persistent hypocalcaemia and malnutrition. This is the first case of a CCS patient with multiple rib fractures. Although the association between CCS and multiple rib fractures in this case remains uncertain, we presume that persistent hypocalcaemia and malnutrition contribute to this situation, or at least aggravate this rare complication. Besides, since prolonged corticosteroid therapy will result in an increased risk of osteoporotic fracture, CCS patients who accept corticosteroid therapy could be potential victims of rib fracture.
Content may be subject to copyright.
CAS E REP O R T Open Access
Cronkhite-Canada syndrome associated with rib
fractures: a case report
Bosi Yuan, Xinxin Jin, Renmin Zhu, Xiaohua Zhang, Jio ng Liu, Haijun Wan, Heng Lu, Yunzhu Shen, Fangyu Wang
*
Abstract
Background: Cronkhite-Canada syndrome (CCS) is a rare multiple gastrointestinal polyposis. Up till now, many
complications of CCS have been reported in the literature, but rib fracture is not included.
Case Presentation: We report a case of a 58-year-old man who was admitted to our hospital with a 6-month
history of frequent diarrhea, intermittent hematochezia and a weight loss of 13 kg. On admission, physical
examination revealed alopecia of the scalp, hyperpigmentation of the hands and soles, and dystrophy of the
fingernails. Laboratory data revealed hypocalcaemia and hypoproteinemia. Esophago gastroduodenoscopy, video
capsule endoscopy and colonoscopy revealed various sizes of generalized gastrointestinal polyps. Histological
examination of the biopsy specimens obtained from the stomach and the colon showed adenomatous polyp and
inflammatory polyp respectively. Thus, a diagnosis of CCS was made. After treatment with corticosteroids for
24 days and nutritional sup port for two months, his clinical condition improved. Two months later, he was
admitted to our hospital for the second time with frequent diarrhea and weight loss. The chest radiography
revealed fractures of the left sixth and seventh ribs. Examinations, including emission computed tomogra phy, bone
densitometry test, and other serum parameters, were performed, but could not identify the definite etiology of the
rib fractures. One month later, the patient suffered from aggravating multiple rib fractures due to the ineffective
treatment, persistent hypocalcaemia and malnutrition.
Conclusions: This is the first case of a CCS patient with multiple rib fractures. Although the association between
CCS and multiple rib fractures in this case remains uncertain, we presume that persistent hypocalcaemia and
malnutrition contribute to this situation, or at least aggravate this rare complication. Besides, since prolonged
corticosteroid therap y will result in an increased risk of osteoporotic fracture, CCS patients who accept
corticosteroid therap y could be potential victims of rib fracture.
Background
Cronkhite-Canada syndrome (CCS) is a rare acquired
polyposis syndrome characterized by multiple gastroin-
testinal polyps with alopecia, nail dystrophy, and hyper-
pigmentation. The syndrome was first reported in 1955
by Cronkhite and Canada [1]. Since then, more than 400
cases of Cronkhite-Canada syndrome had been reported
worldwide, with 75% of them coming from Japan [2].
The mean age of onset is reported to be 59 years, and the
male to female ratio is 3:2 [3]. So far, no definite etiology
of CCS has been determined, though mental stress or
physical fatigue is thought to be involved [4], and no
strong evidence to suggest a f amilial predisposition.
Moreover, various kinds of concomitant diseases of CCS
havebeenreported.HerewedescribeacaseofCCSina
patient with multiple rib fractures.
Case Presentation
A 58-year-old man was admitted to our hospital with a
6-month history of frequent watery diarrhea (10-20 times
per day), intermittent hematochezia, and a weight loss of
13 kg. Two months after onset of symptoms, he noticed
pigmentation in the palms and hair loss. He had a nega-
tive family history of gastrointestinal disease and conge-
nital disease. On physical examination, the patient was
found t o have marked alopecia, brownish macular pig-
mentation over the palms and soles, and o nychodystro-
phy of the fingernails. The remainder of the physical
examination was unremarkable.
* Correspondence: wangfy65@gmail.com
Department of Gastroenterology, Jinling Hospital, Jiangsu province, China
Yuan et al. BMC Gastroenterology 2010, 10:121
http://www.biomedcentral.com/1471-230X/10/121
© 2010 Bosi et al; licensee BioMed Central Ltd. This i s an Open Access article distributed under the terms o f the Creative Commons
Attribution L icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, pro vided the origin al work is properly cited.
Initial laboratory data showed that his albumin level
was 31.2 g/L (normal range 35-55 g/L), serum potas-
sium 3.1 mmol/L (normal range 3.5-5.5 mmol/L) and
serum calcium 1.7 mmol/L (normal range 2.1-2.6
mmol/L). Other blood parameters, including thyroid
hormones, parathyroid hormone and immunoglobulins,
were within the normal range. The chest radiograph was
negative. Esophagogastroduodenoscopy, video capsule
endoscopy and colonoscopy were performed for further
evaluation of the gastrointestinal tract and they identi-
fied various s izes of generalized gastrointestinal polyps
(Figures 1, 2 and 3). Histological examination of the
biopsy specimens obtained from the stomach and the
colon showed adenomatous polyp and inflammatory
polyp respectively. Thus, a diagnosis of CCS was made.
We starte d corticosteroid therapy for him with oral pre-
dnisone (40 mg per day for 2 weeks and then reduced
thedosageto30mgperdayandlasteditfor10days),
but then we discontinued it because the clinical situa-
tion of the pa tient became better . At the same time, the
patient was treated with nutritional supplementation by
parenteral and enteral nutrition. His situation improved
gradually after two months of treatment . The frequenc y
of diarrhea decr eased to 2 times per day, the we ight
increased by 5 kg, and the hair and fingernails regrew,
but the levels of serum calcium (1.9 mmol/L) and albu-
min (30.6 g/L) were still lower than the normal range.
He returne d home for home nutritional support by ent-
eral nutrition.
Two months later, he was admitted to our hospital for
the second time wit h frequent diarrhea (7-8 times per
day) and a weight loss of 7 kg. Laboratory data showed
that his serum albumin level was 28.2 g/L and serum
calcium 1.7 mmol/L. His chest radiograph showed frac-
tures of the left sixth and seventh ribs (Figure 4). Since
the patient had not suffered from any load or trauma in
the chest, this concomitant complicatio n initially led us
to presume that there was a possibility of rib metastasis
of a malignant tumor. Emission Computed Tomography
(ECT) was performed and it showed no increased tracer
uptake in the skeleta l system. Bone densitometry tests
on vertebrae lumbales and caput femoris were normal.
Further examination for checking bone metastasis was
not per formed because of the patient s financial situa-
tion, and his examinations and clinical features indicated
no definite malignant tumor. Since his nutritional status
was poor and he had no complain of pain i n chest,
orthopedic surgeons and che st surgeons advis ed us to
supply calcium and nutrition for him and to restrict his
chest wall movement. After one-month treatmen t,
which was similar t o our previous treatment except for
the corticosteroid therapy, his clinical condition mark-
edly improved again. His serum albumin level increased
to 35.2 g/L and calcium t o 1.9 mmol/L. However, the
rib fractures persisted.
After one-month of home nutritional support, he was
admitted to our hospital for the third time to improve
his nutritional status. His chest radiograph rev ealed
aggravating multiple ri b fractures (Figure 5). S ince he
did not complain of chest pain and respiratory distress
when walking or resting, we consulted the orthopedic
surgeons and chest surgeons again and received the
same treatment recommendations. After one-month
combination therapy, based on nutritional support, his
weight increased by 4.5 kg, but hypocalcaemia (calcium
level, 1.9 m mol/L), hypoalbuminemia (albumin level,
30.9 g/L) and multiple rib fractures still persisted.
Discussion
CCS has been reported over half a century [1]. The symp-
toms of CCS are characterized by the presence of ectoder-
mal abnormalities, including alopecia, onchodystrophy
and cutaneous hyperpigmentation, and they also a sso-
ciated with prominent clinical features, including diarrhea,
Figure 1 Endoscopic views. Esophagogastroduodenoscopy showed diffuse polypoid lesions extending from cardia to the first part o f the
duodenum. A, Cardia; B, Stomach; C, Duodenum.
Yuan et al. BMC Gastroenterology 2010, 10:121
http://www.biomedcentral.com/1471-230X/10/121
Page 2 of 5
weight loss, hypogeusia, anorexia and intestinal malab-
sorption [1,3]. In the present case as well as other reported
cases, endoscopic char acteristics of CCS were impressive
(Figures 1, 2 and 3) and histological examination of polyps
showed diversity in appearance: inflammatory, hyperplastic
and adenomatous types. Although CCS is considered a
benign condition, the occurrence of cancer in the stomach
and colorectum of CCS patients is about 13% (50/387),
and there is a possibility of serrated adenoma-carcinoma
sequence in colorectal cancer [4].
Figure 2 Endoscopic views. Video Capsule Endoscopy showed multiple herpes-like and strawberry-like polyps studded in most of the jejunum
and ileum. A and B, Jejunum; C and D, Ileum.
Figure 3 Endoscopic views. Colonoscopy identified numerous, hyperemic, sessile and pedunculated polyps in the colorectum. A, Descending
Colon; B, Transverse Colon.
Yuan et al. BMC Gastroenterology 2010, 10:121
http://www.biomedcentral.com/1471-230X/10/121
Page 3 of 5
Many complications such as fatal gastrointestinal
bleeding, intussusception, electrolyte abnormalities, pro-
tein-losing enteropathy, and severe acute pancreatitis
may occur with CCS, possibly contributing to poor out-
comes [3,5-8]. Inte restingly, the present case was compli-
cated by r ib fractures, which, to our kno wledg e, has not
been reported in the published literature. Since our
patient had no medical h istory of trauma, persistent
cough, chest pain and congenital disease, and our exami-
nations d id not establish the definite eti ology of the rib
fractures. In addition, low dosage prednisone for 24 days,
in our opinion, could not have resulted in the multiple
rib fract ures. Therefore, we presume that persistent
hypocalcaemia and malnutrition contribute to this situa-
tion, or at least aggravate this rare complication.
Although it is believed that no specific treatment h as
consistently resulted in definite improvement, current lit-
erature favors a combination therapy, which could induce
remission as seen in our patient, based on nutritional
support and corticosteroids [9]. Since prolonged corticos-
teroid therapy will result in an increased risk of osteo-
porotic fracture, CCS patients who accept corticosteroid
treatment should be monit ored for the potential ha rmful
complications such as rib fracture.
Although the overall mortality has been reported as
high as 55% a ccording to an early study [10], the prog-
nosis is now thought to be better than earlier case
reports, with improvement in medical treatment and
increased understanding of the syndrome.
Conclusions
This is the first case of a CCS patient with multiple rib
fractures. Although the association between CCS and
multiple rib fractu res in this case remains uncertain, we
presume that persistent hy pocalcaemia and malnutrition
contribute to this situation, or at least aggravate this
rare complication. Besides, s ince prolonged corticoster-
oid therapy will result in an increased risk of osteoporo-
tic fracture, CCS patients who acce pt corticosteroid for
treatment could be potential victims of rib fracture.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy o f the written consent is available
for review by the Editor-in-Chief of this journal.
Abbreviations
CCS: Cronkhite-Canada syndrome.
Acknowledgements
Written consent was obtained from the patient for publication of this paper.
The authors thank Atsushi Irisawa and Klaus Mönkemüller for their highly
constructive suggesti ons. No financial relationships with a commercial entity
producing health-care related products and/or services relevant to this
article.
Authors contributions
YB reviewed the literature and drafted the manuscript; JX, LH, SY and ZR
created figures, collected clinical data and analyzed data; LJ, JX, WH and LH
were involved in the care of the patient, WF performed the endoscopy; SY,
ZX and WF revised the manuscript. All authors read and approved the final
manuscript.
Figure 4 X-ray image. A chest radiograph showed fractures of the
left sixth and seventh ribs (arrow).
Figure 5 X-ray image. A chest radiograph showed multiple
fractures of the left fourth to seventh ribs (arrow) and right fifth to
ninth ribs (arrow).
Yuan et al. BMC Gastroenterology 2010, 10:121
http://www.biomedcentral.com/1471-230X/10/121
Page 4 of 5
Competing interests
The authors declare that they have no competing interests.
Received: 20 February 2010 Accepted: 18 October 2010
Published: 18 October 2010
References
1. Cronkhite LW Jr, Canada WJ: Generalized gastrointestinal polyposis; an
unusual syndrome of polyposis, pigmentation, alopecia and
onychotrophia. N Engl J Med 1955, 252:1011-1015.
2. Riegert-Johnson DL, Osborn N, Smyrk T, Boardman LA: Cronkhite-Canada
syndrome hamartomatous polyps are infiltrated with IgG4 plasma cells.
Digestion 2007, 75:96-97.
3. Ward EM, Wolfsen HC: Review article: the non-inherited gastrointestinal
polyposis syndromes. Aliment Pharmacol Ther 2002, 16:333-342.
4. Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K:
Cronkhite-Canada syndrome containing colon cancer and serrated
adenoma lesions. Digestion 2004, 69:57-62.
5. Yasuda T, Ueda T, Matsumoto I, Shirasaka D, Nakajima T, Sawa H,
Shinzeki M, Kim Y, Fujino Y, Kuroda Y: Cronkhite-Canada syndrome
presenting as recurrent severe acute pancreatitis. Gastrointest Endosc
2008, 67:570-572.
6. Isomoto H, Urata M, Nakagoe T, Sawai T, Nomoto T, Oda H, Nomura N,
Takeshima F, Mizuta Y, Murase K, Shimada S, Murata I, Kohno S: Proximal
extension of cap polyposis confirmed by colonoscopy. Gastrointest
Endosc 2001, 54:388-391.
7. Mizuno M, Matsumoto T, Iida M, Shimizu M: Magnifying colonoscopic
features in non-neoplastic polyps of the colorectum. Gastrointest Endosc
1997, 46:537-541.
8. Ward EM, Wolfsen HC: Pharmacological management of Cronkhite-
Canada syndrome. Expert Opin Pharmacother 2003, 4:385-389.
9. Chadalavada R, Brown DK, Walker AN, Sedghi S: Cronkhite-Canada
syndrome: sustained remission after corticosteroid treatment. Am J
Gastroenterol 2003, 98:1444-1446.
10. Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD:
The Cronkhite-Canada syndrome. An analysis of clinical and pathologic
features and therapy in 55 patients. Medicine 1982, 61:293-309.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-230X/10/121/prepub
doi:10.1186/1471-230X-10-121
Cite this article as: Yuan et al.: Cronkhite-Canada syndrome associated
with rib fractures: a case report. BMC Gastroenterology 2010 10:121 .
Submit your next manuscript to BioMed Central
and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
Yuan et al. BMC Gastroenterology 2010, 10:121
http://www.biomedcentral.com/1471-230X/10/121
Page 5 of 5
... The colon may have sessile, hemipedunculated, or pedunculated polyps, ranging from 2 to 40 mm [3,12,50,56]. Patients with CCS without polyps may exhibit the following endoscopy findings: mucosal edema and congestion, mosaic-like changes in the gastric mucosa, abnormal duodenal fold with furrowing, and nodular changes in the small intestine [46]. ...
... There are several pathological types of polyps in CCS: inflammatory polyps, hyperplastic polyps, hamartomatous polyps, and adenomatous polyps [28,42,[56][57][58]. In adenomatous polyps, tubular adenoma, tubular adenoma with low-grade intraepithelial neoplasia, and villous tubular adenoma with locally well-differentiated adenocarcinoma have been reported [3,58,59]. ...
... Intestinal mucosal changes in CCS patients lead to malabsorption, hypocalcemia, and vitamin D deficiency, which can ultimately lead to rib fracture and flail chest [56,69]. CCS combined with vestibular dysfunction, arteriovenous thrombosis, and pulmonary embolism has also been reported [70][71][72]. ...
Article
Full-text available
Cronkhite–Canada syndrome (CCS) is a rare acquired polyposis with unknown etiology. To date, >500 cases have been reported worldwide. CCS is typically characterized by gastrointestinal symptoms, such as diarrhea and skin changes (e.g. alopecia, pigmentation, and nail atrophy). Endoscopic features include diffuse polyps throughout the entire gastrointestinal tract, except for the esophagus. Pathological types of polyps in CCS mainly include inflammatory, hyperplastic, hamartomatous, and adenomatous polyps. CCS can be complicated by many diseases and has a canceration tendency with a high mortality rate. Moreover, there is no uniform standard treatment for CCS. A review of the reported cases of CCS is presented herein, with the goal of improving our understanding of this disease.
... There are few studies reporting the use of endoscopic observation for small bowel lesions. Review of small number of previous reports indicates that typical endoscopic findings in CCS include the following: (1) mucosal edema and enlarged villi [12,13] ; ...
... (2) reddened mucosa [12,13] ; (3) white villus or scattered white spots [12,14] ; (4) flat protuberances or small polyps (herpes-like lesions at jejunum [12][13][14][15] ; and strawberry-like lesions at ileum [12,13,16] ; (5) elongated villi [14,16] ; and (6) atrophied villi [2,17] . The above findings (1), (2), (3), (5) and (6) were observed in the present case. ...
... (2) reddened mucosa [12,13] ; (3) white villus or scattered white spots [12,14] ; (4) flat protuberances or small polyps (herpes-like lesions at jejunum [12][13][14][15] ; and strawberry-like lesions at ileum [12,13,16] ; (5) elongated villi [14,16] ; and (6) atrophied villi [2,17] . The above findings (1), (2), (3), (5) and (6) were observed in the present case. ...
Article
Full-text available
We present a case of Cronkhite-Canada syndrome (CCS) in which the entire intestine was observed using a prototype of magnifying single-balloon enteroscope (SIF Y-0007, Olympus). CCS is a rare, non-familial gastrointestinal polyposis with ectodermal abnormalities. To our knowledge, this is the first report showing magnified intestinal lesions of CCS. A 73-year-old female visited our hospital with complaints of diarrhea and dysgeusia. The blood test showed mild anemia and hypoalbuminemia. The esophagogastroduodenoscopy and colonoscopy revealed diffuse and reddened sessile to semi-pedunculated polyps, resulting in the diagnosis of CCS. In addition to the findings of conventional balloon-assisted enteroscopy or capsule endoscopy, magnifying observation revealed tiny granular structures, non-uniformity of the villus, irregular caliber of the loop-like capillaries, scattered white spots in the villous tip, and patchy redness of the villus. Histologically, the scattered white spots and patchy redness of the villus reflect lymphangiectasia and bleeding to interstitium, respectively.
... Steroids are considered the main stay of medical treatment, although the recommended doses and durations vary widely in the literature, with no current gold standard [9,14]. However, CCS patients who receive long-term treatment with corticosteroids usually develop osteoporosis and have an increased risk of rib fractures [17]. In addition, hypocalcemia and malnutrition can predispose to the development of rib fractures. ...
... In addition, hypocalcemia and malnutrition can predispose to the development of rib fractures. Hence, patients with CCS on corticosteroid therapy should be regularly screened for potential complications such as rib fracture [17]. ...
Article
Full-text available
Background: Development of multiple rib fractures leading to bilateral flail chest in Cronkhite-Canada Syndrome (CCS) has not been reported. Case presentation: A 59-year-old man presented with complaints of fatigue, chest pain, respiratory distress and orthopnea requiring ventilatory support to maintain oxygenation. CCS with bilateral anterior and posterior flail chest due to multiple rib fractures (2nd-10th on the right side and 2nd-11th on the left side). He underwent open reduction and anterior and posterior internal fixation using a titanium alloy fixator and a nickel-titanium memory alloy embracing fixator for chest wall reconstruction. He recovered gradually from the ventilator and showed improvement in his symptoms. He gained about 20 kg of weight in the follow up period (6 months after discharge from the hospital). Conclusion: CCS is a rare, complex disease that increases the risk of developing multiple rib fractures, which can be successfully treated with open reduction and internal fixation.
... The Cronkhite-Canada syndrome (CCS) was first reported in 1955, since then more than 500 cases have been reported [1,2], indicating an estimated incidence of one case per 1 million inhabitants. The reported cases of Cronkhite-Canada infant syndrome are scarce (< 10) [3]. ...
... Cutaneous manifestations have been attributed to malabsorption and malnutrition caused by gastrointestinal pathology [4]. Several types of diseases concomitant with CCS have also been reported [1]. No mutations of the PTEN tumor suppressor gene, which is located at 10q23.3 and responsible for another gastrointestinal polyposis syndrome, Cowden's disease, have been in patients with CCS [8]. ...
Article
Full-text available
The Cronkhite-Canada syndrome (CCS) was first reported in 1955, since then more than 500 cases have been reported, indicating an estimated incidence of one case per 1 million inhabitants. The syndrome occurs predominantly in male, with a ratio of three males to two females. Because of the rarity of the syndrome, there are no evidence-based therapies and the treatments described include a combination of therapies, but none is consistently effective. Surgery is usually reserved for the treatment of complications. Herein, we present a case of adolescent CCS. The patient was a 15-year-old boy who presented with watery diarrhea with 20 episodes a day, vomiting and abdominal pain for 4 weeks, with a weight loss of 8.0 kg (15.0% of initial weight). Endoscopic examination revealed polyposis in the stomach, duodenum, and colon. CCS was diagnosed and the patient was treated with a combined corticosteroid and metronidazole. Followed up at 8 month after the diagnosis, the patient was asymptomatic.
... 7,8,18 Corticosteroids are more frequently used to maintain remission although they carry the risk of osteoporotic fracture. 3 Not surprisingly, there have been no controlled trials assessing the optimal dosage or duration of treatment with corticosteroids or azathioprine for the treatment of CCS. Furthermore, following any remission, it is still uncertain whether medication should be continued and if so, at what dose. ...
Article
Full-text available
Infantile hepatic hemangioendothelioma (IHH) is rare which can regress spontaneously. Arteriovenous shunts within hemangiomas, however, may result in pulmonary artery hypertension (PAH) and congestive heart failure (CHF). The authors report 2 young infants suffering from multifocal IHH associated with CHF were both treated with glucocorticoid and transcatheter arterial embolization (TAE), but had different outcomes. The PAH decreased immediately and the symptoms of CHF were alleviated after TAE for both of them. For the Tibetan infant, the development was normal with tumor regression by follow-up. For the Han ethnic neonate, PAH increased again in the seventh day with progressive cardiovascular insufficiency. Ultrasound showed a persisting perfusion caused by collateralization around occluded main feeders. Furthermore, a pulmonary infection occurred and ventilation was performed. As a result, the infant died from multiorgan failure caused by CHF and infection. TAE is a treatment of reducing shunting for hemangiomas. Fistula recanalization in multifocal IHH, however, might be an important risk factor affecting the outcome of TAE. TAE should be further evaluated with special attention to anatomy of feeding and draining vessels, and cardiopulmonary conditions. In addition, the patients were susceptible to secondary pulmonary infection because of lung congestion. As well, the infant from the high altitude area showed better adaptability to hypoxia.
... Recently a case reported Cronkhite-Canada syndrome associated with rib fracture. 12 Patient was prescribed 40 mg prednisolone per day, however he suffered multiple rib fractures after the treatment. It is considered persistent hypocalcaemia and malnutrition may contribute to this situation while prednisolone therapy also resulted in an increased risk of osteoporotic fracture. ...
Article
Cronkhite-Canada syndrome (CCS) is a very rare disease which may cause malignant transformation. A combination regimen including corticosteroids are common therapy for CCS, however the decrease of medicine may lead to CCS relapse and also may contribute to malignant transformation of the polyps in gastrointestinal tract. We retrospectively analyze one case of recurrent CCS from the first time of treatment after resection of colon cancer and readjust the usage of corticoids, the patient recovered well. The nine months follow-up showed non gastrointestinal tumor occurred or relapsed. We believe close follow-up should be taken when CCS patients are making medicine dosage alteration and tumor marker such as CEA may be included in the surveillance examination. When improvement using conservative treatment can be neither obtained nor is expected, the use of surgery should be considered.
Chapter
Cronkhite–Canada syndrome (CCS) is a noninherited condition, associated with high morbidity, and characterized by gastrointestinal inflammatory polyposis, alopecia, onychodystrophy, hyperpigmentation, and diarrhea. The etiology of CCS is unknown, although evidence continues to emerge supporting an autoimmune basis. The diagnosis of CCS is clinicopathological and remains challenging. Corticosteroids and nutritional support remain the cornerstone of management, however, newer immunomodulatory agents have emerged as viable alternatives in recent years. The role of surgery remains limited to complications refractory to medical management. The question of whether polyps in CCS possess malignant potential remains controversial. Optimal cancer screening protocols have not been developed for CCS patients, owing to the rarity of the disease. However, careful surveillance is recommended. In this chapter, we provide a succinct overview of the history, etiology, risk factors, clinical manifestations, diagnosis, and management of CCS. The latest evidence on the pathogenesis of CCS, as well as novel treatment options, will be incorporated. We anticipate that this chapter will enhance the knowledge of clinicians on this rare condition, helping to facilitate an appropriate diagnosis and enhance the management of patients with CCS going forward.
Article
A 64-year-old woman presented with heavy diarrhoea, nausea and weight loss accompanied by alopecia and dystrophic fingernails and toenails. The preceding diagnosis of an inflammatory bowel disease, a common pitfall, was excluded by endoscopic work up. Instead, Cronkhite-Canada syndrome (CCS), a rare polyposis condition, was identified as the reason for this almost pathognomonic combination of diagnostic findings including various polyps throughout the entire intestine and ectodermal abnormalities. This case exemplifies common risks and complications in terms of gastrointestinal malabsorption, infections and small intestinal bacterial overgrowth (SIBO), including its treatment as well as a hereto unreported association with polymyalgia rheumatica. In CCS, long-term immunosuppressive therapy and close endoscopic cancer screening of the patient is essential. The treatment of vitamin deficiency and recurring SIBO helps to reduce symptoms.
Article
Full-text available
Cronkhite-Canada syndrome (CCS) is a rare nongenetic polyposis syndrome first reported by Cronkhite and Canada in 1955.¹ Up to the present time, the literature consists of ∼400 cases of CCS with the majority being reported from Japan² although 49 cases have been described in China.³ CCS is characterized by diffuse polyposis of the digestive tract in association with ectodermal changes, such as onychomadesis, alopecia, and cutaneous hyperpigmentation. The principal symptoms of CCS are diarrhea, weight loss, abdominal pain, and other gastrointestinal complications, such as protein-losing enteropathy and malnutrition. It has been traditional to consider that CCS is associated with a poor prognosis. This paper describes a relatively mild case and reviews the literature, which more recently, suggests that it may be a more benign condition that might actually be reversible with treatment. There is some evidence that infection or disturbed immunity may be involved in the pathophysiology and that targeting such abnormalities could have therapeutic potential. A strong case could be made for establishing an international case registry for this disease so that the pathophysiology, treatment, and prognosis could become much better understood.
Article
The non-inherited gastrointestinal polyposis syndromes represent a group of rare disorders characterized by the presence of multiple, non-adenomatous polyps on the gastrointestinal mucosa occurring in unrelated patients. We present here a review of the clinical and histo- pathological aspects of the syndromes to include the Cronkhite–Canada syndrome, hyperplastic polyposis and lipomatous polyposis. While infrequently encoun- tered, these diseases can have devastating clinical effects that may be aggravated by delays in diagnosis and treatment. Prompt accurate diagnosis and treatment of these uncommon disorders depend on a sound working knowledge of the distinct clinical and pathological features described herein.
Article
The clinical and pathologic features of 55 cases of the Cronkhite-Canada syndrome (CCS) and the results of nutritional, antibiotic, steroid and surgical treatment are analyzed. Associated gastrointestinal malignancies were found in eight patients. Intensive medical treatment with or without surgical intervention in selected cases has been shown to induce symptomatic remissions. Contrary to earlier reports the course of CCS is not relentlessly progressive in all cases and long-term survivals have been documented.
Article
The non-inherited gastrointestinal polyposis syndromes represent a group of rare disorders characterized by the presence of multiple, non-adenomatous polyps on the gastrointestinal mucosa occurring in unrelated patients. We present here a review of the clinical and histo- pathological aspects of the syndromes to include the Cronkhite-Canada syndrome, hyperplastic polyposis and lipomatous polyposis. While infrequently encountered, these diseases can have devastating clinical effects that may be aggravated by delays in diagnosis and treatment. Prompt accurate diagnosis and treatment of these uncommon disorders depend on a sound working knowledge of the distinct clinical and pathological features described herein.
Article
Cronkhite-Canada syndrome (CCS) is a rare, non-inherited gastrointestinal polyposis syndrome associated with characteristic ectodermal abnormalities. A number of potentially life-threatening complications including malnutrition, gastrointestinal bleeding and infection may occur in affected patients and CCS is fatal in many cases. The optimal therapy for CCS is not known but several treatment options have been described. Nutritional support, antibiotics, corticosteroids, anabolic steroids, histamine-receptor antagonists and surgical treatment have all been used with varying degrees of success. Unfortunately, controlled therapeutic trials have not been possible because of the rarity of the disease. Most recently, a combination regimen using histamine-receptor antagonists, cromolyn sodium, prednisone and suppressive antibiotics has been described. The reported treatment options and rates of success are reviewed.
Article
The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print. www.amjgastro.com, *2007 Journal Citation Report (Thomson Reuters, 2008)
Article
TWO cases are reported below in which the presenting complaints were disturbances in gastrointestinal function, pigmentation of the skin, alopecia and atrophy of the fingernails and toenails. In each case the underlying pathologic process seemed to be generalized gastrointestinal polyposis in which virtually the entire gastrointestinal mucosa was replaced by polypoid lesions. These cases are of interest in that they probably differ in nature from other syndromes that relate polyposis to pigmentation of the skin. Case Reports CASE 1. E.S. (B.M. 733228), a 42-year-old single female bookkeeper, was first seen in March, 1951, because of nausea, vomiting and diarrhea of . . .
Article
We describe a case of Cronkhite-Canada syndrome associated with sigmoid colon cancer, and provide a literature review. A 77-year-old man was diagnosed with sigmoid colon cancer after presenting with hypoproteinemia, nail atrophy, loss of scalp hair, hyperpigmentation, and gastrointestinal polyposis. The findings were consistent with Cronkhite-Canada syndrome. The colon polyps were histologically serrated adenomas, whose crypts showed a saw-toothed growth pattern with dysplasia, or tubular adenoma. Cronkhite-Canada syndrome associated with colon cancer has been reported in 31 cases. The availability of histologic material permitted reexamination of 25 of these cases. Serrated adenoma of the polypoid lesions was retrospectively found in 10 (40%) of the 25 cases. By comparison, the incidence of serrated adenomas has been estimated to occur in about 1% of all general polyps. Taken together, it is suggested that Cronkhite-Canada syndrome associated with colorectal cancer frequently has polyps containing serrated adenoma lesions. In the case described here, microsatellite instability and overexpression of the p53 protein were found in the cancer lesion and serrated adenoma lesions, and none of the lesions showed a loss of heterozygosity of various genes or K-RAS mutations. Thus, genetic alterations between the serrated adenoma and the colorectal cancer was correlated in this case. These findings suggested the possibility of a serrated adenoma-carcinoma sequence in this case of Cronkhite-Canada syndrome.